James Cassella
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
James V.
Cassella is currently Chief Development Officer at Trevi Therapeutics, Inc. since 2024.
Formerly, Chief Development Officer at Sun Pharmaceutical Industries, Inc. from 2023 to 2024.
Chief Development Officer & Senior Vice President at Concert Pharmaceuticals, Inc. from 2015 to 2023.
CSO, Executive VP-Research & Development at Alexza Pharmaceuticals, Inc. from 2013 to 2015.
Senior VP-Clinical Research & Development at Neurogen Corp.
from 1989 to 2004.
Assistant Professor at Oberlin College.
Education includes a doctorate from Dartmouth College and an undergraduate degree from the University of New Haven.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Corporate Officer/Principal | 30/09/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
Sun Pharmaceutical Industries, Inc.
Sun Pharmaceutical Industries, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/09/2024 |
| CONCERT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2023 |
| ALEXZA PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 29/01/2015 |
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Directeur Technique/Scientifique/R&D | 01/06/2004 |
Oberlin College
Oberlin College Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 8 |
|---|---|
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Alexza Pharmaceuticals, Inc.
Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the acute treatment of central nervous system conditions | Health Technology |
Concert Pharmaceuticals, Inc.
Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines | Health Technology |
Oberlin College
Oberlin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dartmouth College
Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New Haven
University of New Haven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sun Pharmaceutical Industries, Inc.
Sun Pharmaceutical Industries, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Trevi Therapeutics, Inc.
Trevi Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment for cough conditions | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national